Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body

Journal of Applied Physiology

Volumn 96, Issue 2, 2004, Pages 809-813

  Lam, Siu Yin ^a   Fung, Man Lung ^b   Leung, Po Sing ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiotensin II; Captopril; Chronic hypoxia; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALTITUDE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID BODY; CONTROLLED STUDY; DOWN REGULATION; ELECTROLYTE BALANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; FLUID BALANCE; HOMEOSTASIS; HYPOXIA; MALE; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANGIOTENSIN II; ANIMALS; ANOXIA; CAROTID BODY; ENZYME ACTIVATION; FLUORESCENCE; MALE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM;

EID: 0942276798     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00684.2003     Document Type: Article

References (56)

1. Aldashev AA, Sarybaev AS, Sydykov AS, Kalmyrzaev BB, Kim EV, Mamanova LB, Maripov R, Kojonazarov BK, Mirrakhimov MM, Wilkins MR, and Morrell NW. Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype. Am J Respir Crit Care Med 166: 1396-1402, 2002.
2. Alvarez R, Reguero JR, Batalla A, Iglesias-Cubero G, Cortina A, Alvarez V, and Coto E. Angiotensin-converting enzyme and angiotensin II receptor I polymorphisms: association with early coronary disease. Cardiovasc Res 40: 375-379, 1998.
3. Alvarez R, Terrados N, Ortolano R, Iglesias-Cubero G, Reguero JR, Batalla A, Cortina A, Fernandez-Garcia B, Rodriguez C, Braga S, Alvarez V, and Coto E. Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol 82: 117-120, 2000.
4. Campell DJ. Tissue renin-angiotensin system: sites of angiotensin formation. J Cardiovasc Pharmacol 10: 1-8, 1987.
5. Catt KJ, Cain MD, Coghlan JP, Zimmet PZ, Cran E, and Best JB. Metabolism and blood levels of angiotensin II in normal subjects, renal disease, and essential hypertension. Circ Res 27: 177-193, 1970.
6. Chan WP, Fung ML, Nobiling R, and Leung PS. Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas. Mol Cell Endocrinol 160: 107-114, 2000.
7. Chassagne C, Eddahibi S, Adamy C, Rideau D, Marotte F, Dubois-Rande JL, Adnot S, Samuel JL, and Teiger E. Modulation of angiotensin II receptor expression during development and regression of hypoxic hypertension. Am J Respir Cell Mol Biol 22: 323-332, 2000.
8. Colice GL, Lawrason J, Munsef A, Bittle P, Dietz J, and Ramirez G. Hormonal response to exercise in high altitude natives and COPD patients. Aviat Space Environ Med 64: 512-516, 1993.
9. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, and Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 92: 1387-1388, 1995.
10. Danser AH and Schunkert H. Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases. Eur J Pharmacol 410: 303-316, 2000.
11. Doggrell SA. Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease? Expert Opin Pharmacother 3: 1543-1556, 2001.
12. Dzau VJ. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol 6: 377-382, 1984.
13. Dzau VJ, Burt DW, and Pratt RE. Molecular biology of the renin-angiotensin system. Am J Physiol Renal Fluid Electrolyte Physiol 255: F563-F573, 1988.
14. Fletcher EC. Physiological and genomic consequences of intermittent hypoxia. J Appl Physiol 90: 1600-1605, 2001.
15. Fletcher EC, Bao G, and Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34: 309-314, 1999.
16. Fung ML, Lam SY, Chen Y, Dong X, and Leung PS. Functional expression of angiotensin II receptors in type-I cells of the rat carotid body. Pflügers Arch 441: 474-480, 2001.
17. 1a angiotensin receptors in rat carotid body chemoreceptors. J Endocrinol 173: 305-313, 2002.
18. Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS, and Trent RJ. Elite endurance athletes and the ACE I allele - the role of genes in athletic performance. Hum Genet 103: 48-50, 1998.
19. Honig A. Peripheral arterial chemoreceptors and control of sodium and water homeostasis. Am J Physiol Regul Integr Comp Physiol 257: R1282-R1302, 1989.
20. Hooper NM, Keen J, Pappin DJ, and Turner AJ. Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane. Biochem J 247: 85-93, 1987.
21. Ip SP, Chan YW, and Leung PS. Effects of chronic hypoxia on the circulating and pancreatic renin-angiotensin system. Pancreas 25: 296-300, 2002.
22. Ip SP, Kwan PC, Williams CH, Pang S, Hooper NM, and Leung PS. Changes of angiotensin-converting enzyme activity in the pancreas of chronic hypoxia and acute pancreatitis. Int J Biochem Cell Biol 35: 944-954, 2003.
23. Jederlinic P, Hill NS, Ou LC, and Fanburg BL. Lung angiotensin converting enzyme activity in rats with differing susceptibilities to chronic hypoxia. Thorax 43: 703-707, 1988.
24. Kay JM, Keane PM, Suyama KL, and Gauthier D. Lung angiotensin converting enzyme activity in chronically hypoxic rats. Thorax 40: 587-591, 1985.
25. Lahiri S, Di Giulio C, and Roy A. Lessons from chronic intermittent and sustained hypoxia at high altitudes. Respir Physiol Neurobiol 130: 223-233, 2002.
26. Lam SY and Leung PS. A locally generated angiotensin system in rat carotid body. Regul Pept 107: 97-103, 2002.
27. Lam SY and Leung PS. Chronic hypoxia activates a local angiotensin-generating system in rat carotid body. Mol Cell Endocrinol 203: 147-153, 2003.
28. Leung PS, Chan WP, and Nobiling R. Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis. Mol Cell Endocrinol 166: 121-128, 2002.
29. Leung PS and Chappell MC. A local pancreatic renin-angiotensin system: endocrine and exocrine roles. Int J Biochem Cell Biol 35: 838-846, 2003.
30. Leung PS, Fung ML, and Sernia C. Chronic hypoxia induced down-regulation of angiotensinogen expression in rat epididymis. Regul. Pept 96: 143-149, 2001.
31. Leung PS, Fung ML, and Tam SC. Renin-angiotensin system in the carotid body. Int J Biochem Cell Biol 35: 847-854, 2003.
32. 1 receptor in rat carotid body. J Endocrinol 167: 517-524, 2000.
33. Leung PS and Sernia C. The renin-angiotensin system and male reproduction: new functions for old hormones. J Mol Endocrinol 30: 263-270, 2003.
34. Li P, Chen PM, Wang SW, and Chen LY. Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload. Hypertens Res 25: 757-762, 2002.
35. Milledge JS and Catley DM. Angiotensin converting enzyme response to hypoxia in man: its role in altitude acclimatization. Clin Sci (Lond) 67: 453-456, 1984.
36. Milledge JS, Catley DM, Blume FD, and West JB. Renin, angiotensin-converting enzyme, and aldosterone in humans on Mount Everest. J Appl Physiol 55: 1109-1112, 1983.
37. Molinaro G, Adam A, Lepage Y, Hammerschmidt D, Koenigbauer U, and Eastlund T. Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation. Transfusion 42: 1458-1465, 2002.
38. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA, Hemingway H, Statters D, Jubb M, Girvain M, Varnava A, World M, Deanfield J, Talmud P, McEwan JR, McKenna WJ, and Humphries S. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96: 741-747, 1997.
39. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, Hayward M, Holliman DE, Jubb M, World M, Thomas EL, Brynes AE, Saeed N, Barnard M, Bell JD, Prasad K, Rayson M, Talmud PJ, and Humphries SE. Human gene for physical performance. Nature 393: 221-222, 1998.
40. Morrell NW, Atochina EN, Morris KG, Danilov SM, and Stenmark KR. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest 96: 1823-1833, 1995.
41. Morrell NW, Danilov SW, Satyan KB, Morris KG, and Stenmark KR. Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary, hypertension. Cardiovasc Res 34: 393-403, 1997.
42. Morrell NW, Morris KG, and Stenmark KR. Role of angiotensin converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol Heart Circ Physiol 269: H1186-H1194, 1995.
43. Neylon M, Marshall J, and Johns EJ. The role of the renin-angiotensin system in the renal response to moderate hypoxia in the rat. J Physiol 491: 479-499, 1996.
44. Ng KKF and Vane JR. Conversion of angiotensin to angiotensin II. Nature 216: 762-766, 1967.
45. Oparil S, Narkates AJ, Jackson RM, and Ann HS. Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats. J Appl Physiol 65: 218-227, 1988.
46. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313-370, 1977.
47. Phillips MI, Speakman EA, and Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 43: 1-20, 1993.
48. Prabhakar NR. Oxygen sensing by the carotid body chemoreceptors. J Appl Physiol 88: 2287-2295, 2000.
49. Ramirez G, Hammond M, Agosti SJ, Bittle PA, Dietz JR, and Colice GL. Effects of hypoxemia at sea level and high altitude on sodium excretion and hormonal levels. Aviat Space Environ Med 63: 891-898, 1992.
50. Rigat B, Hubert C, Alhene-Gelas F, Cambien F, Corvol P, and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346, 1990.
51. Vane JR. The fate of angiotensin I. In: Handbook of Experimental Pharmacology, Angiotensin, edited by Page IH and Bumpus FM. New York: Springer-Verlag, 1974, vol. 37, p. 17-39.
52. Wang ZY and Bisgard GE. Chronic hypoxia-induced morphological and neurochemical changes in the carotid body. Microsc Res Tech 59: 168-177, 2002.
53. Woods DR, Pollard AJ, Collier DJ, Jamshidi Y, Vassiliou V, Hawe E, Humphries SE, and Montgomery HE. Insertion/deletion polymorphism of the angiotensin 1-converting enzyme gene and arterial oxygen saturation at high altitude. Am J Respir Crit Care Med 166: 362-366, 2002.
54. Yu TZ and Ma CT. Effect of hypoxia on angiotensin-converting enzyme activity and gene expression of intrapulmonary artery smooth muscle cells. Sheng Li Xue Bao 50: 623-628, 1998.
55. Zaccaria M, Rocco S, Noventa D, Varnier M, and Opocher G. Sodium regulating hormones at high altitude: basal and post-exercise levels. J Clin Endocrinol Metab 83: 570-574, 1998.
56. Zhao L, al-Tubuly R, Sebkhi A, Owji AA, Nunez DJ, and Wilkins MR. Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung. Br J Pharmacol 119: 1217-1222, 1996.